TY  - GEN
AU  - Faloppi,Luca
AU  - Bianconi,Maristella
AU  - Giampieri,Riccardo
AU  - Sobrero,Alberto
AU  - Labianca,Roberto
AU  - Ferrari,Daris
AU  - Barni,Sandro
AU  - Aitini,Enrico
AU  - Zaniboni,Alberto
AU  - Boni,Corrado
AU  - Caprioni,Francesco
AU  - Mosconi,Stefania
AU  - Fanello,Silvia
AU  - Berardi,Rossana
AU  - Bittoni,Alessandro
AU  - Andrikou,Kalliopi
AU  - Cinquini,Michela
AU  - Torri,Valter
AU  - Scartozzi,Mario
AU  - Cascinu,Stefano
TI  - The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
SN  - 1949-2553
PY  - 2016///0830
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - blood
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - L-Lactate Dehydrogenase
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Pancreatic Neoplasms
KW  - Phenylurea Compounds
KW  - Prognosis
KW  - Sorafenib
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.18632/oncotarget.5197
ER  -